Home » Topics » Briefs » Other news to note

Other news to note
RSS

Kadmon planning phase II trials of KD-025 in three indications

Oct. 17, 2013

MedImmune acquires biotech company and invests in ADC Therapeutics

Oct. 15, 2013

Clavis Pharma becomes Aqualis

Oct. 15, 2013

Mesoblast acquires Osiris' culture-expanded mesenchymal stem cell business

Oct. 15, 2013

Otsuka acquires Astex Pharmaceuticals

Oct. 14, 2013

Novartis licenses ImmunoGen technology

Oct. 14, 2013

Nycomed to return worldwide rights to veltuzumab

Oct. 10, 2013

Bayer selects drug candidates for accelerated development and expands indications for approved drugs

Oct. 9, 2013

GSK adds development candidate to its collaboration with Isis

Oct. 8, 2013

Amplimmune acquisition strengthens MedImmune's oncology pipeline

Oct. 7, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...